Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shuanghuang Shengbai Oral Liquid for preventing leukopenia after chemotherapy for lung cancer
ChiCTR-IIR-16009398Phase 4Not yet recruiting
- Sponsor
- Longhua Hospital Shanghai University of Traditional Chinese Medicine
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of shuanghuang shengbai in bronchial carcinoma and chemotherapy-induced leukopenia (CIL) (2 arms), sponsored by Longhua Hospital Shanghai University of Traditional Chinese Medicine. Primary endpoint: Incidence and extent of leukocyte reduction. Planned start Nov 2016; status: not yet recruiting.
02
Drugs
shuanghuang shengbai
03
Conditions
bronchial carcinomachemotherapy-induced leukopenia (CIL)
Beyond the preview
Go deeper on ChiCTR-IIR-16009398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-16009398.